메뉴 건너뛰기




Volumn 13, Issue 6, 2013, Pages 581-599

Colorectal cancer diagnostics: Biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis

Author keywords

biomarkers; cell free DNA; circulating tumor cells; colon cancer; colorectal cancer; microsatellite instability; plasma DNA; single cell profiling

Indexed keywords

B RAF KINASE; BEVACIZUMAB; CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; EPITHELIAL CELL ADHESION MOLECULE; IRINOTECAN; K RAS PROTEIN; MEMBRANE PROTEIN; OXALIPLATIN; PANITUMUMAB; SMAD4 PROTEIN; TUMOR MARKER;

EID: 84881098877     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2013.811896     Document Type: Review
Times cited : (47)

References (168)
  • 4
    • 33846436108 scopus 로고    scopus 로고
    • Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (seer) program
    • Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12(1), 20-37 (2007
    • (2007) Oncologist , vol.12 , Issue.1 , pp. 20-37
    • Hayat, M.J.1    Howlader, N.2    Reichman, M.E.3    Edwards, B.K.4
  • 5
    • 84877358772 scopus 로고    scopus 로고
    • Stage at diagnosis and colorectal cancer survival in six high-income countries: A populationbased study of patients diagnosed during 2000-2007
    • ICBP Module 1 Working Group
    • Maringe C, Walters S, Rachet B et al.; ICBP Module 1 Working Group Stage at diagnosis and colorectal cancer survival in six high-income countries: A populationbased study of patients diagnosed during 2000-2007. Acta Oncol. 52(5), 919-932 (2013
    • (2013) Acta Oncol , vol.52 , Issue.5 , pp. 919-932
    • Maringe, C.1    Walters, S.2    Rachet, B.3
  • 6
    • 84856523631 scopus 로고    scopus 로고
    • Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics results of a german prospective multicentre observational study
    • Mantke R, Schmidt U, Wolff S, Kube R, Lippert H. Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study. Eur. J. Surg. Oncol. 38(3), 259-265 (2012
    • (2012) Eur. J. Surg. Oncol , vol.38 , Issue.3 , pp. 259-265
    • Mantke, R.1    Schmidt, U.2    Wolff, S.3    Kube, R.4    Lippert, H.5
  • 7
  • 8
    • 77957194333 scopus 로고    scopus 로고
    • Epidemiology, management and prognosis of colorectal cancer with lung metastases: A 30-year population-based study
    • Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM. Epidemiology, management and prognosis of colorectal cancer with lung metastases: A 30-year population-based study. Gut 59(10), 1383-1388 (2010
    • (2010) Gut , vol.59 , Issue.10 , pp. 1383-1388
    • Mitry, E.1    Guiu, B.2    Cosconea, S.3    Jooste, V.4    Faivre, J.5    Bouvier, A.M.6
  • 9
    • 0035912144 scopus 로고    scopus 로고
    • Molecular predictors of survival after adjuvant chemotherapy for colon cancer
    • Watanabe T, Wu TT, Catalano PJ et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 344(16), 1196-1206 (2001
    • (2001) N. Engl. J. Med , vol.344 , Issue.16 , pp. 1196-1206
    • Watanabe, T.1    Wu, T.T.2    Catalano, P.J.3
  • 10
    • 33846595479 scopus 로고    scopus 로고
    • ASCO ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
    • Locker GY, Hamilton S, Harris J et al.; ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24(33), 5313-5327 (2006
    • (2006) J. Clin. Oncol , vol.24 , Issue.33 , pp. 5313-5327
    • Locker, G.Y.1    Hamilton, S.2    Harris, J.3
  • 11
    • 0018077833 scopus 로고
    • Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer
    • Wanebo HJ, Rao B, Pinsky CM et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N. Engl. J. Med. 299(9), 448-451 (1978
    • (1978) N. Engl. J. Med , vol.299 , Issue.9 , pp. 448-451
    • Wanebo, H.J.1    Rao, B.2    Pinsky, C.M.3
  • 12
    • 0019217947 scopus 로고
    • The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers
    • Goslin R, Steele G Jr, Macintyre J et al. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann. Surg. 192(6), 747-751 (1980
    • (1980) Ann. Surg , vol.192 , Issue.6 , pp. 747-751
    • Goslin, R.1    Steele Jr., G.2    Macintyre, J.3
  • 13
    • 0021356204 scopus 로고
    • The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer results from nsabp (national surgical adjuvant breast and bowel project) clinical trials
    • Wolmark N, Fisher B, Wieand HS et al. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Ann. Surg. 199(4), 375-382 (1984
    • (1984) Ann. Surg , vol.199 , Issue.4 , pp. 375-382
    • Wolmark, N.1    Fisher, B.2    Wieand, H.S.3
  • 14
    • 84878525484 scopus 로고    scopus 로고
    • Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer
    • Laubert T, Bente V, Freitag-Wolf S et al. Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer. Int. J. Colorectal Dis. 28(6), 767-775 (2013
    • (2013) Int. J. Colorectal Dis , vol.28 , Issue.6 , pp. 767-775
    • Laubert, T.1    Bente, V.2    Freitag-Wolf, S.3
  • 15
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
    • discussion 318
    • Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann. Surg. 230(3), 309-18; discussion 318 (1999
    • (1999) Ann. Surg , vol.230 , Issue.3 , pp. 309-318
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3    Brennan, M.F.4    Blumgart, L.H.5
  • 16
    • 0029881854 scopus 로고    scopus 로고
    • Surgical resection of colorectal carcinoma metastases to the liver a prognostic scoring system to improve case selection, based on 1568 patients association française de chirurgie
    • Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 77(7), 1254-1262 (1996
    • (1996) Cancer , vol.77 , Issue.7 , pp. 1254-1262
    • Nordlinger, B.1    Guiguet, M.2    Vaillant, J.C.3
  • 17
    • 0041160895 scopus 로고    scopus 로고
    • The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer
    • Wichmann MW, Müller C, Lau-Werner U et al. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. Langenbecks. Arch. Surg. 385(4), 271-275 (2000
    • (2000) Langenbecks. Arch. Surg , vol.385 , Issue.4 , pp. 271-275
    • Wichmann, M.W.1    Müller, C.2    Lau-Werner, U.3
  • 18
    • 33644696421 scopus 로고    scopus 로고
    • American society of clinical oncology colorectal cancer surveillance: 2005 update of an american society of clinical oncology practice guideline
    • Desch CE, Benson AB 3rd, Somerfield MR et al.; American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J. Clin. Oncol. 23(33), 8512-8519 (2005
    • (2005) J. Clin. Oncol , vol.23 , Issue.33 , pp. 8512-8519
    • Desch, C.E.1    Benson III, A.B.2    Somerfield, M.R.3
  • 19
    • 24744451447 scopus 로고    scopus 로고
    • Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer
    • Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 23(4), 338-351 (2005
    • (2005) Cancer Invest , vol.23 , Issue.4 , pp. 338-351
    • Goldstein, M.J.1    Mitchell, E.P.2
  • 20
    • 33846620129 scopus 로고    scopus 로고
    • Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: A receiver operating characteristic curve analysis
    • Körner H, Söreide K, Stokkeland PJ, Söreide JA. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: A receiver operating characteristic curve analysis. Ann. Surg. Oncol. 14(2), 417-423 (2007
    • (2007) Ann. Surg. Oncol , vol.14 , Issue.2 , pp. 417-423
    • Körner, H.1    Söreide, K.2    Stokkeland, P.J.3    Söreide, J.A.4
  • 21
    • 0035104009 scopus 로고    scopus 로고
    • CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA
    • Hanke B, Riedel C, Lampert S et al. CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA). Ann. Oncol. 12(2), 221-226 (2001
    • (2001) Ann. Oncol , vol.12 , Issue.2 , pp. 221-226
    • Hanke, B.1    Riedel, C.2    Lampert, S.3
  • 22
    • 0031804961 scopus 로고    scopus 로고
    • DNA mismatch repair and cancer
    • Prolla TA. DNA mismatch repair and cancer. Curr. Opin. Cell Biol. 10(3), 311-316 (1998
    • (1998) Curr. Opin. Cell Biol , vol.10 , Issue.3 , pp. 311-316
    • Prolla, T.A.1
  • 23
    • 34548680283 scopus 로고    scopus 로고
    • DNA mismatch repair and colon cancer
    • Marra G, Jiricny J. DNA mismatch repair and colon cancer. Adv. Exp. Med. Biol. 570, 85-123 (2005
    • (2005) Adv. Exp. Med. Biol , vol.570 , pp. 85-123
    • Marra, G.1    Jiricny, J.2
  • 24
    • 84869048414 scopus 로고    scopus 로고
    • Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer
    • Roth AD, Delorenzi M, Tejpar S et al. Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J. Natl Cancer Inst. 104(21), 1635-1646 (2012
    • (2012) J. Natl Cancer Inst , vol.104 , Issue.21 , pp. 1635-1646
    • Roth, A.D.1    Delorenzi, M.2    Tejpar, S.3
  • 25
    • 63849088630 scopus 로고    scopus 로고
    • Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
    • Van Cutsem E, Köhne CH, Hitre E et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N. Engl. J. Med. 360(14), 1408-1417 (2009
    • (2009) N. Engl. J. Med , vol.360 , Issue.14 , pp. 1408-1417
    • Van Cutsem, E.1    Köhne, C.H.2    Hitre, E.3
  • 26
    • 79956298812 scopus 로고    scopus 로고
    • Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status
    • Van Cutsem E, Köhne CH, Láng I et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J. Clin. Oncol. 29(15), 2011-2019 (2011
    • (2011) J. Clin. Oncol , vol.29 , Issue.15 , pp. 2011-2019
    • Van Cutsem, E.1    Köhne, C.H.2    Láng, I.3
  • 27
    • 79956310674 scopus 로고    scopus 로고
    • Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: The OPUS study
    • Bokemeyer C, Bondarenko I, Hartmann JT et al. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: The OPUS study. Ann. Oncol. 22(7), 1535-1546 (2011
    • (2011) Ann. Oncol , vol.22 , Issue.7 , pp. 1535-1546
    • Bokemeyer, C.1    Bondarenko, I.2    Hartmann, J.T.3
  • 28
    • 78149250536 scopus 로고    scopus 로고
    • Randomized, phase iii trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (folfox4) versus folfox4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The prime study
    • Douillard JY, Siena S, Cassidy J et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study. J. Clin. Oncol. 28(31), 4697-4705 (2010
    • (2010) J. Clin. Oncol , vol.28 , Issue.31 , pp. 4697-4705
    • Douillard, J.Y.1    Siena, S.2    Cassidy, J.3
  • 29
    • 79959337678 scopus 로고    scopus 로고
    • Mrc coin trial investigators addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 mrc coin trial
    • Maughan TS, Adams RA, Smith CG et al.; MRC COIN Trial Investigators. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised Phase 3 MRC COIN trial. Lancet 377(9783), 2103-2114 (2011
    • (2011) Lancet , vol.377 , Issue.9783 , pp. 2103-2114
    • Maughan, T.S.1    Adams, R.A.2    Smith, C.G.3
  • 30
    • 84861432557 scopus 로고    scopus 로고
    • Phase iii trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (nordic flox) versus flox alone in first-line treatment of metastatic colorectal cancer: The nordic-vii study
    • Tveit KM, Guren T, Glimelius B et al. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII study. J. Clin. Oncol. 30(15), 1755-1762 (2012
    • (2012) J. Clin. Oncol , vol.30 , Issue.15 , pp. 1755-1762
    • Tveit, K.M.1    Guren, T.2    Glimelius, B.3
  • 31
    • 75749102647 scopus 로고    scopus 로고
    • Prognostic role of kras and braf in stage ii and iii resected colon cancer: Results of the translational study on the petacc-3, eortc 40993, sakk 60-00 trial
    • Roth AD, Tejpar S, Delorenzi M et al. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: Results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J. Clin. Oncol. 28(3), 466-474 (2010
    • (2010) J. Clin. Oncol , vol.28 , Issue.3 , pp. 466-474
    • Roth, A.D.1    Tejpar, S.2    Delorenzi, M.3
  • 32
    • 77955277111 scopus 로고    scopus 로고
    • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis
    • De Roock W, Claes B, Bernasconi D et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis. Lancet Oncol. 11(8), 753-762 (2010
    • (2010) Lancet Oncol , vol.11 , Issue.8 , pp. 753-762
    • De Roock, W.1    Claes, B.2    Bernasconi, D.3
  • 33
    • 77954215850 scopus 로고    scopus 로고
    • Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab
    • Tol J, Dijkstra JR, Klomp M et al. Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab. Eur. J. Cancer 46(11), 1997-2009 (2010
    • (2010) Eur. J. Cancer , vol.46 , Issue.11 , pp. 1997-2009
    • Tol, J.1    Dijkstra, J.R.2    Klomp, M.3
  • 34
    • 84862026304 scopus 로고    scopus 로고
    • Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-Type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
    • Bokemeyer C, Van Cutsem E, Rougier P et al. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-Type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials. Eur. J. Cancer 48(10), 1466-1475 (2012
    • (2012) Eur. J. Cancer , vol.48 , Issue.10 , pp. 1466-1475
    • Bokemeyer, C.1    Van Cutsem, E.2    Rougier, P.3
  • 35
    • 84859885193 scopus 로고    scopus 로고
    • BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: An aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features
    • Pai RK, Jayachandran P, Koong AC et al. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: An aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am. J. Surg. Pathol. 36(5), 744-752 (2012
    • (2012) Am. J. Surg. Pathol , vol.36 , Issue.5 , pp. 744-752
    • Pai, R.K.1    Jayachandran, P.2    Koong, A.C.3
  • 36
    • 84861863158 scopus 로고    scopus 로고
    • EGFR-mediated re-Activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib
    • Corcoran RB, Ebi H, Turke AB et al. EGFR-mediated re-Activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov. 2(3), 227-235 (2012
    • (2012) Cancer Discov , vol.2 , Issue.3 , pp. 227-235
    • Corcoran, R.B.1    Ebi, H.2    Turke, A.B.3
  • 37
    • 84873360893 scopus 로고    scopus 로고
    • Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents
    • Mao M, Tian F, Mariadason JM et al. Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. Clin. Cancer Res. 19(3), 657-667 (2013
    • (2013) Clin. Cancer Res , vol.19 , Issue.3 , pp. 657-667
    • Mao, M.1    Tian, F.2    Mariadason, J.M.3
  • 38
    • 84863012433 scopus 로고    scopus 로고
    • Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer
    • Yang H, Higgins B, Kolinsky K et al. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. Cancer Res. 72(3), 779-789 (2012
    • (2012) Cancer Res , vol.72 , Issue.3 , pp. 779-789
    • Yang, H.1    Higgins, B.2    Kolinsky, K.3
  • 39
    • 0028321495 scopus 로고
    • Allelic loss of chromosome 18q and prognosis in colorectal cancer
    • Jen J, Kim H, Piantadosi S et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 331(4), 213-221 (1994
    • (1994) N. Engl. J. Med , vol.331 , Issue.4 , pp. 213-221
    • Jen, J.1    Kim, H.2    Piantadosi, S.3
  • 40
    • 25144456860 scopus 로고    scopus 로고
    • A systematic review and meta-Analysis of the relationship between chromosome 18q genotype dcc status and colorectal cancer prognosis
    • Popat S, Houlston RS. A systematic review and meta-Analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur. J. Cancer 41(14), 2060-2070 (2005
    • (2005) Eur. J. Cancer , vol.41 , Issue.14 , pp. 2060-2070
    • Popat, S.1    Houlston, R.S.2
  • 41
    • 0037010411 scopus 로고    scopus 로고
    • Ukcccr axis trial collaborators adjuvant x-ray and fluorouracil infusion study dna markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: A molecular study
    • Barratt PL, Seymour MT, Stenning SP et al.; UKCCCR AXIS trial collaborators. Adjuvant X-ray and Fluorouracil Infusion Study. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: A molecular study. Lancet 360(9343), 1381-1391 (2002
    • (2002) Lancet , vol.360 , Issue.9343 , pp. 1381-1391
    • Barratt, P.L.1    Seymour, M.T.2    Stenning, S.P.3
  • 42
    • 76749132120 scopus 로고    scopus 로고
    • Prognostic significance and molecular associations of 18q loss of heterozygosity: A cohort study of microsatellite stable colorectal cancers
    • Ogino S, Nosho K, Irahara N et al. Prognostic significance and molecular associations of 18q loss of heterozygosity: A cohort study of microsatellite stable colorectal cancers. J. Clin. Oncol. 27(27), 4591-4598 (2009
    • (2009) J. Clin. Oncol , vol.27 , Issue.27 , pp. 4591-4598
    • Ogino, S.1    Nosho, K.2    Irahara, N.3
  • 43
    • 20244365185 scopus 로고    scopus 로고
    • SMAD4 as a prognostic marker in colorectal cancer
    • Alazzouzi H, Alhopuro P, Salovaara R et al. SMAD4 as a prognostic marker in colorectal cancer. Clin. Cancer Res. 11(7), 2606-2611 (2005
    • (2005) Clin. Cancer Res , vol.11 , Issue.7 , pp. 2606-2611
    • Alazzouzi, H.1    Alhopuro, P.2    Salovaara, R.3
  • 44
    • 24344444413 scopus 로고    scopus 로고
    • SMAD4 levels and response to 5-fluorouracil in colorectal cancer
    • Alhopuro P, Alazzouzi H, Sammalkorpi H et al. SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin. Cancer Res. 11(17), 6311-6316 (2005
    • (2005) Clin. Cancer Res , vol.11 , Issue.17 , pp. 6311-6316
    • Alhopuro, P.1    Alazzouzi, H.2    Sammalkorpi, H.3
  • 45
    • 77249140520 scopus 로고    scopus 로고
    • Antimetastatic role of Smad4 signaling in colorectal cancer
    • e1
    • Zhang B, Halder SK, Kashikar ND et al. Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 138(3), 969-80.e1 (2010
    • (2010) Gastroenterology , vol.138 , Issue.3 , pp. 969-980
    • Zhang, B.1    Halder, S.K.2    Kashikar, N.D.3
  • 46
    • 0037048331 scopus 로고    scopus 로고
    • SMAD4 is a predictive marker for 5-fluorouracilbased chemotherapy in patients with colorectal cancer
    • Boulay JL, Mild G, Lowy A et al. SMAD4 is a predictive marker for 5-fluorouracilbased chemotherapy in patients with colorectal cancer. Br. J. Cancer 87(6), 630-634 (2002
    • (2002) Br. J. Cancer , vol.87 , Issue.6 , pp. 630-634
    • Boulay, J.L.1    Mild, G.2    Lowy, A.3
  • 47
    • 0642306985 scopus 로고    scopus 로고
    • Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis
    • Xie W, Rimm DL, Lin Y, Shih WJ, Reiss M. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. Cancer J. 9(4), 302-312 (2003
    • (2003) Cancer J. , vol.9 , Issue.4 , pp. 302-312
    • Xie, W.1    Rimm, D.L.2    Lin, Y.3    Shih, W.J.4    Reiss, M.5
  • 48
    • 6044259206 scopus 로고    scopus 로고
    • Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
    • Allard WJ, Matera J, Miller MC et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10(20), 6897-6904 (2004
    • (2004) Clin. Cancer Res , vol.10 , Issue.20 , pp. 6897-6904
    • Allard, W.J.1    Matera, J.2    Miller, M.C.3
  • 49
    • 0021024191 scopus 로고
    • Correlation between circulating cancer cells and incidence of metastases
    • Glaves D. Correlation between circulating cancer cells and incidence of metastases. Br. J. Cancer 48(5), 665-673 (1983
    • (1983) Br. J. Cancer , vol.48 , Issue.5 , pp. 665-673
    • Glaves, D.1
  • 50
    • 0021213017 scopus 로고
    • Quantitation of tumorigenic disseminating and arrested cancer cells
    • Mayhew E, Glaves D. Quantitation of tumorigenic disseminating and arrested cancer cells. Br. J. Cancer 50(2), 159-166 (1984
    • (1984) Br. J. Cancer , vol.50 , Issue.2 , pp. 159-166
    • Mayhew, E.1    Glaves, D.2
  • 52
    • 0020076985 scopus 로고
    • Metastatic inefficiency in mice bearing B16 melanomas
    • Weiss L, Mayhew E, Rapp DG, Holmes JC. Metastatic inefficiency in mice bearing B16 melanomas. Br. J. Cancer 45(1), 44-53 (1982
    • (1982) Br. J. Cancer , vol.45 , Issue.1 , pp. 44-53
    • Weiss, L.1    Mayhew, E.2    Rapp, D.G.3    Holmes, J.C.4
  • 53
    • 0031655802 scopus 로고    scopus 로고
    • Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases
    • Luzzi KJ, MacDonald IC, Schmidt EE et al. Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153(3), 865-873 (1998
    • (1998) Am. J. Pathol , vol.153 , Issue.3 , pp. 865-873
    • Luzzi, K.J.1    MacDonald, I.C.2    Schmidt, E.E.3
  • 54
    • 0035138203 scopus 로고    scopus 로고
    • Apoptosis: An early event in metastatic inefficiency
    • Wong CW, Lee A, Shientag L et al. Apoptosis: An early event in metastatic inefficiency. Cancer Res. 61(1), 333-338 (2001
    • (2001) Cancer Res , vol.61 , Issue.1 , pp. 333-338
    • Wong, C.W.1    Lee, A.2    Shientag, L.3
  • 55
    • 0026600988 scopus 로고
    • Lethal deformation of cancer cells in the microcirculation: A potential rate regulator of hematogenous metastasis
    • Weiss L, Nannmark U, Johansson BR, Bagge U. Lethal deformation of cancer cells in the microcirculation: A potential rate regulator of hematogenous metastasis. Int. J. Cancer 50(1), 103-107 (1992
    • (1992) Int. J. Cancer , vol.50 , Issue.1 , pp. 103-107
    • Weiss, L.1    Nannmark, U.2    Johansson, B.R.3    Bagge, U.4
  • 56
    • 0027257162 scopus 로고
    • Cancer-cell traffic in the liver III Lethal deformation of B16 melanoma cells in liver sinusoids
    • Barbera-Guillem E, Weiss L. Cancer-cell traffic in the liver. III Lethal deformation of B16 melanoma cells in liver sinusoids. Int. J. Cancer 54(5), 880-884 (1993
    • (1993) Int. J. Cancer , vol.54 , Issue.5 , pp. 880-884
    • Barbera-Guillem, E.1    Weiss, L.2
  • 57
    • 16844378813 scopus 로고    scopus 로고
    • Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells
    • Berezovskaya O, Schimmer AD, Glinskii AB et al. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res. 65(6), 2378-2386 (2005
    • (2005) Cancer Res , vol.65 , Issue.6 , pp. 2378-2386
    • Berezovskaya, O.1    Schimmer, A.D.2    Glinskii, A.B.3
  • 58
    • 84876948946 scopus 로고    scopus 로고
    • Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
    • Chen CL, Mahalingam D, Osmulski P et al. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate 73(8), 813-826 (2013
    • (2013) Prostate , vol.73 , Issue.8 , pp. 813-826
    • Chen, C.L.1    Mahalingam, D.2    Osmulski, P.3
  • 59
    • 0033972059 scopus 로고    scopus 로고
    • Intravascular origin of metastasis from the proliferation of endothelium-Attached tumor cells: A new model for metastasis
    • Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-Attached tumor cells: A new model for metastasis. Nat. Med. 6(1), 100-102 (2000
    • (2000) Nat. Med , vol.6 , Issue.1 , pp. 100-102
    • Al-Mehdi, A.B.1    Tozawa, K.2    Fisher, A.B.3    Shientag, L.4    Lee, A.5    Muschel, R.J.6
  • 60
    • 0038418255 scopus 로고    scopus 로고
    • Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium
    • Glinsky VV, Glinsky GV, Glinskii OV et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res. 63(13), 3805-3811 (2003
    • (2003) Cancer Res , vol.63 , Issue.13 , pp. 3805-3811
    • Glinsky, V.V.1    Glinsky, G.V.2    Glinskii, O.V.3
  • 61
    • 31144464938 scopus 로고    scopus 로고
    • Dual-color-coded imaging of viable circulating prostate carcinoma cells reveals genetic exchange between tumor cells in vivo, contributing to highly metastatic phenotypes
    • Glinsky GV, Glinskii AB, Berezovskaya O et al. Dual-color-coded imaging of viable circulating prostate carcinoma cells reveals genetic exchange between tumor cells in vivo, contributing to highly metastatic phenotypes. Cell Cycle 5(2), 191-197 (2006
    • (2006) Cell Cycle , vol.5 , Issue.2 , pp. 191-197
    • Glinsky, G.V.1    Glinskii, A.B.2    Berezovskaya, O.3
  • 62
    • 70349230857 scopus 로고    scopus 로고
    • In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential
    • Tome Y, Tsuchiya H, Hayashi K et al. In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential. J. Cell. Biochem. 108(2), 362-367 (2009
    • (2009) J. Cell. Biochem , vol.108 , Issue.2 , pp. 362-367
    • Tome, Y.1    Tsuchiya, H.2    Hayashi, K.3
  • 63
    • 84860397754 scopus 로고    scopus 로고
    • Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
    • Kallergi G, Papadaki MA, Politaki E, Mavroudis D, Georgoulias V, Agelaki S. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res. 13(3), R59 (2011
    • (2011) Breast Cancer Res , vol.13 , Issue.3
    • Kallergi, G.1    Papadaki, M.A.2    Politaki, E.3    Mavroudis, D.4    Georgoulias, V.5    Agelaki, S.6
  • 64
    • 84855987633 scopus 로고    scopus 로고
    • Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
    • Kasimir-Bauer S, Hoffmann O, Wallwiener D, Kimmig R, Fehm T. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res. 14(1), R15 (2012
    • (2012) Breast Cancer Res , vol.14 , Issue.1
    • Kasimir-Bauer, S.1    Hoffmann, O.2    Wallwiener, D.3    Kimmig, R.4    Fehm, T.5
  • 65
    • 75449106680 scopus 로고    scopus 로고
    • Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
    • Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 11(4), R46 (2009
    • (2009) Breast Cancer Res , vol.11 , Issue.4
    • Aktas, B.1    Tewes, M.2    Fehm, T.3    Hauch, S.4    Kimmig, R.5    Kasimir-Bauer, S.6
  • 66
    • 80055001749 scopus 로고    scopus 로고
    • Detection of circulating tumour cells with a hybrid (epithelial/ mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
    • Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br. J. Cancer 105(9), 1338-1341 (2011
    • (2011) Br. J. Cancer , vol.105 , Issue.9 , pp. 1338-1341
    • Lecharpentier, A.1    Vielh, P.2    Perez-Moreno, P.3    Planchard, D.4    Soria, J.C.5    Farace, F.6
  • 67
    • 82955187028 scopus 로고    scopus 로고
    • Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
    • Raimondi C, Gradilone A, Naso G et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res. Treat. 130(2), 449-455 (2011
    • (2011) Breast Cancer Res. Treat , vol.130 , Issue.2 , pp. 449-455
    • Raimondi, C.1    Gradilone, A.2    Naso, G.3
  • 68
    • 80051988763 scopus 로고    scopus 로고
    • Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers
    • Armstrong AJ, Marengo MS, Oltean S et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol. Cancer Res. 9(8), 997-1007 (2011
    • (2011) Mol. Cancer Res , vol.9 , Issue.8 , pp. 997-1007
    • Armstrong, A.J.1    Marengo, M.S.2    Oltean, S.3
  • 69
    • 84873811988 scopus 로고    scopus 로고
    • Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
    • Yu M, Bardia A, Wittner BS et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119), 580-584 (2013
    • (2013) Science , vol.339 , Issue.6119 , pp. 580-584
    • Yu, M.1    Bardia, A.2    Wittner, B.S.3
  • 70
    • 81255205399 scopus 로고    scopus 로고
    • Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis
    • Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20(5), 576-590 (2011
    • (2011) Cancer Cell , vol.20 , Issue.5 , pp. 576-590
    • Labelle, M.1    Begum, S.2    Hynes, R.O.3
  • 71
    • 84856411831 scopus 로고    scopus 로고
    • A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
    • Khoja L, Backen A, Sloane R et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br. J. Cancer 106(3), 508-516 (2012
    • (2012) Br. J. Cancer , vol.106 , Issue.3 , pp. 508-516
    • Khoja, L.1    Backen, A.2    Sloane, R.3
  • 72
    • 70349729970 scopus 로고    scopus 로고
    • Epithelial-mesenchymal transition and cell cooperativity in metastasis
    • Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 69(18), 7135-7139 (2009
    • (2009) Cancer Res , vol.69 , Issue.18 , pp. 7135-7139
    • Tsuji, T.1    Ibaragi, S.2    Hu, G.F.3
  • 73
    • 33645758275 scopus 로고    scopus 로고
    • Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton
    • Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9(4), 261-272 (2006
    • (2006) Cancer Cell , vol.9 , Issue.4 , pp. 261-272
    • Wicki, A.1    Lehembre, F.2    Wick, N.3    Hantusch, B.4    Kerjaschki, D.5    Christofori, G.6
  • 74
    • 84880270290 scopus 로고    scopus 로고
    • Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
    • Baccelli I, Schneeweiss A, Riethdorf S et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. (2013
    • (2013) Nat. Biotechnol
    • Baccelli, I.1    Schneeweiss, A.2    Riethdorf, S.3
  • 75
    • 79953766940 scopus 로고    scopus 로고
    • Tumour evolution inferred by single-cell sequencing
    • Navin N, Kendall J, Troge J et al. Tumour evolution inferred by single-cell sequencing. Nature 472(7341), 90-94 (2011
    • (2011) Nature , vol.472 , Issue.7341 , pp. 90-94
    • Navin, N.1    Kendall, J.2    Troge, J.3
  • 76
    • 84863393080 scopus 로고    scopus 로고
    • Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
    • Gerlinger M, Rowan AJ, Horswell S et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366(10), 883-892 (2012
    • (2012) N. Engl. J. Med , vol.366 , Issue.10 , pp. 883-892
    • Gerlinger, M.1    Rowan, A.J.2    Horswell, S.3
  • 77
    • 84876674310 scopus 로고    scopus 로고
    • KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
    • Mostert B, Jiang Y, Sieuwerts AM et al. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. Int. J. Cancer 133(1), 130-141 (2013
    • (2013) Int. J. Cancer , vol.133 , Issue.1 , pp. 130-141
    • Mostert, B.1    Jiang, Y.2    Sieuwerts, A.M.3
  • 78
    • 0035433139 scopus 로고    scopus 로고
    • K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells
    • Thebo JS, Senagore AJ, Krygier S, Luchtefeld MA. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells. Am. Surg. 67(8), 802-805 (2001
    • (2001) Am. Surg , vol.67 , Issue.8 , pp. 802-805
    • Thebo, J.S.1    Senagore, A.J.2    Krygier, S.3    Luchtefeld, M.A.4
  • 79
    • 84872048462 scopus 로고    scopus 로고
    • Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/ PIK3CA in circulating tumor cells of patients with colorectal cancer
    • Gasch C, Bauernhofer T, Pichler M et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/ PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin. Chem. 59(1), 252-260 (2013
    • (2013) Clin. Chem , vol.59 , Issue.1 , pp. 252-260
    • Gasch, C.1    Bauernhofer, T.2    Pichler, M.3
  • 80
    • 84860356499 scopus 로고    scopus 로고
    • Biomarkers characterization of circulating tumour cells in breast cancer patients
    • Nadal R, Fernandez A, Sanchez-Rovira P et al. Biomarkers characterization of circulating tumour cells in breast cancer patients. Breast Cancer Res. 14(3), R71 (2012
    • (2012) Breast Cancer Res , vol.14 , Issue.3
    • Nadal, R.1    Fernandez, A.2    Sanchez-Rovira, P.3
  • 81
    • 84879007968 scopus 로고    scopus 로고
    • Tumorigenic potential of circulating prostate tumor cells
    • Carvalho FL, Simons BW, Antonarakis ES et al. Tumorigenic potential of circulating prostate tumor cells. Oncotarget 4(3), 413-421 (2013
    • (2013) Oncotarget , vol.4 , Issue.3 , pp. 413-421
    • Carvalho, F.L.1    Simons, B.W.2    Antonarakis, E.S.3
  • 82
    • 84860601923 scopus 로고    scopus 로고
    • Single cell profiling of circulating tumor cells: Transcriptional heterogeneity and diversity from breast cancer cell lines
    • Powell AA, Talasaz AH, Zhang H et al. Single cell profiling of circulating tumor cells: Transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 7(5), e33788 (2012
    • (2012) PLoS ONE , vol.7 , Issue.5
    • Powell, A.A.1    Talasaz, A.H.2    Zhang, H.3
  • 83
    • 84865139080 scopus 로고    scopus 로고
    • Compartmental differences of circulating tumor cells in colorectal cancer
    • Rahbari NN, Bork U, Kircher A et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann. Surg. Oncol. 19(7), 2195-2202 (2012
    • (2012) Ann. Surg. Oncol , vol.19 , Issue.7 , pp. 2195-2202
    • Rahbari, N.N.1    Bork, U.2    Kircher, A.3
  • 84
    • 84871990259 scopus 로고    scopus 로고
    • Biologic challenges in the detection of circulating tumor cells
    • Joosse SA, Pantel K. Biologic challenges in the detection of circulating tumor cells. Cancer Res. 73(1), 8-11 (2013
    • (2013) Cancer Res , vol.73 , Issue.1 , pp. 8-11
    • Joosse, S.A.1    Pantel, K.2
  • 85
    • 67849124183 scopus 로고    scopus 로고
    • Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
    • Mostert B, Sleijfer S, Foekens JA, Gratama JW. Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer. Cancer Treat. Rev. 35(5), 463-474 (2009
    • (2009) Cancer Treat. Rev , vol.35 , Issue.5 , pp. 463-474
    • Mostert, B.1    Sleijfer, S.2    Foekens, J.A.3    Gratama, J.W.4
  • 86
    • 84855952224 scopus 로고    scopus 로고
    • Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
    • Patriarca C, Macchi RM, Marschner AK, Mellstedt H. Epithelial cell adhesion molecule expression (CD326) in cancer: A short review. Cancer Treat. Rev. 38(1), 68-75 (2012
    • (2012) Cancer Treat. Rev , vol.38 , Issue.1 , pp. 68-75
    • Patriarca, C.1    Macchi, R.M.2    Marschner, A.K.3    Mellstedt, H.4
  • 87
    • 67651003100 scopus 로고    scopus 로고
    • The emerging role of EpCAM in cancer and stem cell signaling
    • Munz M, Baeuerle PA, Gires O. The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 69(14), 5627-5629 (2009
    • (2009) Cancer Res , vol.69 , Issue.14 , pp. 5627-5629
    • Munz, M.1    Baeuerle, P.A.2    Gires, O.3
  • 88
    • 84876767651 scopus 로고    scopus 로고
    • Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer
    • Neki K, Kawahara H, Watanabe K, Toyama Y, Akiba T, Yanaga K. Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer. Anticancer Res. 33(4), 1769-1772 (2013
    • (2013) Anticancer Res , vol.33 , Issue.4 , pp. 1769-1772
    • Neki, K.1    Kawahara, H.2    Watanabe, K.3    Toyama, Y.4    Akiba, T.5    Yanaga, K.6
  • 89
    • 20144385756 scopus 로고    scopus 로고
    • Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
    • Cristofanilli M, Hayes DF, Budd GT et al. Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol. 23(7), 1420-1430 (2005
    • (2005) J. Clin. Oncol , vol.23 , Issue.7 , pp. 1420-1430
    • Cristofanilli, M.1    Hayes, D.F.2    Budd, G.T.3
  • 90
    • 49249130844 scopus 로고    scopus 로고
    • Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
    • Cohen SJ, Punt CJ, Iannotti N et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26(19), 3213-3221 (2008
    • (2008) J. Clin. Oncol , vol.26 , Issue.19 , pp. 3213-3221
    • Cohen, S.J.1    Punt, C.J.2    Iannotti, N.3
  • 91
    • 58149165081 scopus 로고    scopus 로고
    • Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
    • de Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14(19), 6302-6309 (2008
    • (2008) Clin. Cancer Res , vol.14 , Issue.19 , pp. 6302-6309
    • De Bono, J.S.1    Scher, H.I.2    Montgomery, R.B.3
  • 92
    • 84873817306 scopus 로고    scopus 로고
    • Relationship among circulating tumor cells cea and overall survival in patients with metastatic colorectal cancer
    • Aggarwal C, Meropol NJ, Punt CJ et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann. Oncol. 24(2), 420-428 (2013
    • (2013) Ann. Oncol , vol.24 , Issue.2 , pp. 420-428
    • Aggarwal, C.1    Meropol, N.J.2    Punt, C.J.3
  • 93
    • 84880329544 scopus 로고    scopus 로고
    • Prognostic value of emt-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantation
    • Mego M, Gao H, Lee BN et al. Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation. J. Cancer 3, 369-380 (2012
    • (2012) J. Cancer , vol.3 , pp. 369-380
    • Mego, M.1    Gao, H.2    Lee, B.N.3
  • 94
    • 77954624770 scopus 로고    scopus 로고
    • Significance of circulating tumor cells detected by the cellsearch system in patients with metastatic breast colorectal and prostate cancer
    • Miller MC, Doyle GV, Terstappen LW. Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J. Oncol. 2010, 617421 (2010
    • (2010) J. Oncol , vol.2010 , pp. 617421
    • Miller, M.C.1    Doyle, G.V.2    Terstappen, L.W.3
  • 95
    • 62649158232 scopus 로고    scopus 로고
    • Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
    • Talasaz AH, Powell AA, Huber DE et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl Acad. Sci. USA 106(10), 3970-3975 (2009
    • (2009) Proc. Natl Acad. Sci. USA , vol.106 , Issue.10 , pp. 3970-3975
    • Talasaz, A.H.1    Powell, A.A.2    Huber, D.E.3
  • 96
    • 21244499767 scopus 로고    scopus 로고
    • Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells
    • Zieglschmid V, Hollmann C, Gutierrez B et al. Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res. 25(3A), 1803-1810 (2005
    • (2005) Anticancer Res , vol.25 , Issue.3 A , pp. 1803-1810
    • Zieglschmid, V.1    Hollmann, C.2    Gutierrez, B.3
  • 97
    • 37549002543 scopus 로고    scopus 로고
    • Isolation of rare circulating tumour cells in cancer patients by microchip technology
    • Nagrath S, Sequist LV, Maheswaran S et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173), 1235-1239 (2007
    • (2007) Nature , vol.450 , Issue.7173 , pp. 1235-1239
    • Nagrath, S.1    Sequist, L.V.2    Maheswaran, S.3
  • 98
    • 78649872067 scopus 로고    scopus 로고
    • Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
    • Stott SL, Hsu CH, Tsukrov DI et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl Acad. Sci. USA 107(43), 18392-18397 (2010
    • (2010) Proc. Natl Acad. Sci. USA , vol.107 , Issue.43 , pp. 18392-18397
    • Stott, S.L.1    Hsu, C.H.2    Tsukrov, D.I.3
  • 99
    • 77957075043 scopus 로고    scopus 로고
    • Microfluidic sorting and multimodal typing of cancer cells in self-Assembled magnetic arrays
    • Saliba AE, Saias L, Psychari E et al. Microfluidic sorting and multimodal typing of cancer cells in self-Assembled magnetic arrays. Proc. Natl Acad. Sci. USA 107(33), 14524-14529 (2010
    • (2010) Proc. Natl Acad. Sci. USA , vol.107 , Issue.33 , pp. 14524-14529
    • Saliba, A.E.1    Saias, L.2    Psychari, E.3
  • 100
    • 79954619582 scopus 로고    scopus 로고
    • High-Throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-Abundance circulating tumor cells using a microfluidic system
    • Dharmasiri U, Njoroge SK, Witek MA et al. High-Throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-Abundance circulating tumor cells using a microfluidic system. Anal. Chem. 83(6), 2301-2309 (2011
    • (2011) Anal. Chem , vol.83 , Issue.6 , pp. 2301-2309
    • Dharmasiri, U.1    Njoroge, S.K.2    Witek, M.A.3
  • 101
    • 84875970076 scopus 로고    scopus 로고
    • Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells
    • 179ra47
    • Ozkumur E, Shah AM, Ciciliano JC et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 5(179), 179ra47 (2013
    • (2013) Sci. Transl. Med , vol.5 , Issue.179
    • Ozkumur, E.1    Shah, A.M.2    Ciciliano, J.C.3
  • 102
    • 77949360268 scopus 로고    scopus 로고
    • Well plate-coupled microfluidic devices designed for facile image-based cell adhesion and transmigration assays
    • Conant CG, Schwartz MA, Ionescu-Zanetti C. Well plate-coupled microfluidic devices designed for facile image-based cell adhesion and transmigration assays. J. Biomol. Screen. 15(1), 102-106 (2010
    • (2010) J. Biomol. Screen , vol.15 , Issue.1 , pp. 102-106
    • Conant, C.G.1    Schwartz, M.A.2    Ionescu-Zanetti, C.3
  • 103
    • 84866509291 scopus 로고    scopus 로고
    • A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire
    • Saucedo-Zeni N, Mewes S, Niestroj R et al. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int. J. Oncol. (2012
    • (2012) Int. J. Oncol
    • Saucedo-Zeni, N.1    Mewes, S.2    Niestroj, R.3
  • 104
    • 77952430114 scopus 로고    scopus 로고
    • Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods
    • Königsberg R, Gneist M, Jahn-Kuch D et al. Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods. Cancer Lett. 293(1), 117-123 (2010
    • (2010) Cancer Lett , vol.293 , Issue.1 , pp. 117-123
    • Königsberg, R.1    Gneist, M.2    Jahn-Kuch, D.3
  • 105
    • 3042849126 scopus 로고    scopus 로고
    • Detection of isolated tumor cells in peripheral blood and in BM: Evaluation of a new enrichment method
    • Naume B, Borgen E, Tøssvik S, Pavlak N, Oates D, Nesland JM. Detection of isolated tumor cells in peripheral blood and in BM: Evaluation of a new enrichment method. Cytotherapy 6(3), 244-252 (2004
    • (2004) Cytotherapy , vol.6 , Issue.3 , pp. 244-252
    • Naume, B.1    Borgen, E.2    Tøssvik, S.3    Pavlak, N.4    Oates, D.5    Nesland, J.M.6
  • 106
    • 35748973274 scopus 로고    scopus 로고
    • Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood
    • Tong X, Yang L, Lang JC, Zborowski M, Chalmers JJ. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Cytometry B. Clin. Cytom. 72(5), 310-323 (2007
    • (2007) Cytometry B. Clin. Cytom , vol.72 , Issue.5 , pp. 310-323
    • Tong, X.1    Yang, L.2    Lang, J.C.3    Zborowski, M.4    Chalmers, J.J.5
  • 107
    • 77951922478 scopus 로고    scopus 로고
    • Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostatespecific antibody
    • Gleghorn JP, Pratt ED, Denning D et al. Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostatespecific antibody. Lab Chip 10(1), 27-29 (2010
    • (2010) Lab Chip , vol.10 , Issue.1 , pp. 27-29
    • Gleghorn, J.P.1    Pratt, E.D.2    Denning, D.3
  • 108
    • 0033891393 scopus 로고    scopus 로고
    • Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulatingtumor cells
    • Vona G, Sabile A, Louha M et al. Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am. J. Pathol. 156(1), 57-63 (2000
    • (2000) Am. J. Pathol , vol.156 , Issue.1 , pp. 57-63
    • Vona, G.1    Sabile, A.2    Louha, M.3
  • 109
    • 80052511419 scopus 로고    scopus 로고
    • A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
    • Farace F, Massard C, Vimond N et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br. J. Cancer 105(6), 847-853 (2011
    • (2011) Br. J. Cancer , vol.105 , Issue.6 , pp. 847-853
    • Farace, F.1    Massard, C.2    Vimond, N.3
  • 110
    • 79953251573 scopus 로고    scopus 로고
    • A new device for rapid isolation by size and characterization of rare circulating tumor cells
    • Desitter I, Guerrouahen BS, Benali-Furet N et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res. 31(2), 427-441 (2011
    • (2011) Anticancer Res , vol.31 , Issue.2 , pp. 427-441
    • Desitter, I.1    Guerrouahen, B.S.2    Benali-Furet, N.3
  • 111
    • 80755172534 scopus 로고    scopus 로고
    • Detection of E coli O157:H7 by immunomagnetic separation coupled with fluorescence immunoassay
    • Zhu P, Shelton DR, Li S et al. Detection of E. coli O157:H7 by immunomagnetic separation coupled with fluorescence immunoassay. Biosens. Bioelectron. 30(1), 337-341 (2011
    • (2011) Biosens. Bioelectron , vol.30 , Issue.1 , pp. 337-341
    • Zhu, P.1    Shelton, D.R.2    Li, S.3
  • 112
    • 77958037272 scopus 로고    scopus 로고
    • Portable filter-based microdevice for detection and characterization of circulating tumor cells
    • Lin HK, Zheng S, Williams AJ et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res. 16(20), 5011-5018 (2010
    • (2010) Clin. Cancer Res , vol.16 , Issue.20 , pp. 5011-5018
    • Lin, H.K.1    Zheng, S.2    Williams, A.J.3
  • 113
    • 73449098612 scopus 로고    scopus 로고
    • Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients
    • Lu J, Fan T, Zhao Q et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int. J. Cancer 126(3), 669-683 (2010
    • (2010) Int. J. Cancer , vol.126 , Issue.3 , pp. 669-683
    • Lu, J.1    Fan, T.2    Zhao, Q.3
  • 114
    • 78649737519 scopus 로고    scopus 로고
    • Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients
    • Tan SJ, Lakshmi RL, Chen P, Lim WT, Yobas L, Lim CT. Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens. Bioelectron. 26(4), 1701-1705 (2010
    • (2010) Biosens. Bioelectron , vol.26 , Issue.4 , pp. 1701-1705
    • Tan, S.J.1    Lakshmi, R.L.2    Chen, P.3    Lim, W.T.4    Yobas, L.5    Lim, C.T.6
  • 115
    • 84874309411 scopus 로고    scopus 로고
    • Isolation and retrieval of circulating tumor cells using centrifugal forces
    • Hou HW, Warkiani ME, Khoo BL et al. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci. Rep. 3, 1259 (2013
    • (2013) Sci. Rep , vol.3 , Issue.1259
    • Hou, H.W.1    Warkiani, M.E.2    Khoo, B.L.3
  • 116
    • 79961142670 scopus 로고    scopus 로고
    • Dynamic physical properties of dissociated tumor cells revealed by dielectrophoretic field-flow fractionation
    • Shim S, Gascoyne P, Noshari J, Hale KS. Dynamic physical properties of dissociated tumor cells revealed by dielectrophoretic field-flow fractionation. Integr. Biol. (Camb). 3(8), 850-862 (2011
    • (2011) Integr. Biol. (Camb , vol.3 , Issue.8 , pp. 850-862
    • Shim, S.1    Gascoyne, P.2    Noshari, J.3    Hale, K.S.4
  • 117
    • 84875793897 scopus 로고    scopus 로고
    • Correlations between the dielectric properties and exterior morphology of cells revealed by dielectrophoretic field-flow fractionation
    • Gascoyne PR, Shim S, Noshari J, Becker FF, Stemke-Hale K. Correlations between the dielectric properties and exterior morphology of cells revealed by dielectrophoretic field-flow fractionation. Electrophoresis 34(7), 1042-1050 (2013
    • (2013) Electrophoresis , vol.34 , Issue.7 , pp. 1042-1050
    • Gascoyne, P.R.1    Shim, S.2    Noshari, J.3    Becker, F.F.4    Stemke-Hale, K.5
  • 118
    • 79952265771 scopus 로고    scopus 로고
    • Cytomorphology of circulating colorectal tumor cells: A small case series
    • Marrinucci D, Bethel K, Lazar D et al. Cytomorphology of circulating colorectal tumor cells: A small case series. J. Oncol. 2010, 861341 (2010
    • (2010) J. Oncol , vol.2010 , pp. 861341
    • Marrinucci, D.1    Bethel, K.2    Lazar, D.3
  • 119
    • 84863043341 scopus 로고    scopus 로고
    • Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients
    • Shimada R, Iinuma H, Akahane T, Horiuchi A, Watanabe T. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients. Oncol. Rep. 27(4), 947-953 (2012
    • (2012) Oncol. Rep , vol.27 , Issue.4 , pp. 947-953
    • Shimada, R.1    Iinuma, H.2    Akahane, T.3    Horiuchi, A.4    Watanabe, T.5
  • 120
    • 84868632393 scopus 로고    scopus 로고
    • Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients
    • de Albuquerque A, Kubisch I, Stölzel U et al. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients. J. Transl. Med. 10, 222 (2012
    • (2012) J. Transl. Med , vol.10 , pp. 222
    • De Albuquerque, A.1    Kubisch, I.2    Stölzel, U.3
  • 121
    • 33947505827 scopus 로고    scopus 로고
    • Usefulness and clinical significance of quantitative real-Time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer
    • Iinuma H, Okinaga K, Egami H et al. Usefulness and clinical significance of quantitative real-Time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int. J. Oncol. 28(2), 297-306 (2006
    • (2006) Int. J. Oncol , vol.28 , Issue.2 , pp. 297-306
    • Iinuma, H.1    Okinaga, K.2    Egami, H.3
  • 122
    • 33846444679 scopus 로고    scopus 로고
    • Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma
    • Allen-Mersh TG, McCullough TK, Patel H, Wharton RQ, Glover C, Jonas SK. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br. J. Surg. 94(1), 96-105 (2007
    • (2007) Br. J. Surg , vol.94 , Issue.1 , pp. 96-105
    • Allen-Mersh, T.G.1    McCullough, T.K.2    Patel, H.3    Wharton, R.Q.4    Glover, C.5    Jonas, S.K.6
  • 123
    • 84860571431 scopus 로고    scopus 로고
    • EPISPOT assay: Detection of viable DTCs/CTCs in solid tumor patients
    • Alix-Panabières C. EPISPOT assay: Detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res. 195, 69-76 (2012
    • (2012) Recent Results Cancer Res , vol.195 , pp. 69-76
    • Alix-Panabières, C.1
  • 124
    • 84875999237 scopus 로고    scopus 로고
    • Plastin3 is a novel marker for circulating tumor cells undergoing the epithelialmesenchymal transition and is associated with colorectal cancer prognosis
    • Yokobori T, Iinuma H, Shimamura T et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelialmesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 73(7), 2059-2069 (2013
    • (2013) Cancer Res , vol.73 , Issue.7 , pp. 2059-2069
    • Yokobori, T.1    Iinuma, H.2    Shimamura, T.3
  • 125
    • 30644472381 scopus 로고    scopus 로고
    • Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
    • Went P, Vasei M, Bubendorf L et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br. J. Cancer 94(1), 128-135 (2006
    • (2006) Br. J. Cancer , vol.94 , Issue.1 , pp. 128-135
    • Went, P.1    Vasei, M.2    Bubendorf, L.3
  • 126
    • 84876111096 scopus 로고    scopus 로고
    • Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
    • Sun YF, Xu Y, Yang XR et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 57(4), 1458-1468 (2013
    • (2013) Hepatology , vol.57 , Issue.4 , pp. 1458-1468
    • Sun, Y.F.1    Xu, Y.2    Yang, X.R.3
  • 127
    • 84878196648 scopus 로고    scopus 로고
    • Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer
    • Pesta M, Fichtl J, Kulda V, Topolcan O, Treska V. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Anticancer Res. 33(5), 2239-2243 (2013
    • (2013) Anticancer Res , vol.33 , Issue.5 , pp. 2239-2243
    • Pesta, M.1    Fichtl, J.2    Kulda, V.3    Topolcan, O.4    Treska, V.5
  • 128
    • 79952737532 scopus 로고    scopus 로고
    • Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer
    • Papavasiliou P, Fisher T, Kuhn J, Nemunaitis J, Lamont J. Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Proc. (Bayl. Univ. Med. Cent). 23(1), 11-14 (2010
    • (2010) Proc. (Bayl. Univ. Med. Cent , vol.23 , Issue.1 , pp. 11-14
    • Papavasiliou, P.1    Fisher, T.2    Kuhn, J.3    Nemunaitis, J.4    Lamont, J.5
  • 129
    • 74949093965 scopus 로고    scopus 로고
    • Unique localization of circulating tumor cells in patients with hepatic metastases
    • Jiao LR, Apostolopoulos C, Jacob J et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J. Clin. Oncol. 27(36), 6160-6165 (2009
    • (2009) J. Clin. Oncol , vol.27 , Issue.36 , pp. 6160-6165
    • Jiao, L.R.1    Apostolopoulos, C.2    Jacob, J.3
  • 131
    • 18344382135 scopus 로고    scopus 로고
    • Combined transcriptome and genome analysis of single micrometastatic cells
    • Klein CA, Seidl S, Petat-Dutter K et al. Combined transcriptome and genome analysis of single micrometastatic cells. Nat. Biotechnol. 20(4), 387-392 (2002
    • (2002) Nat. Biotechnol , vol.20 , Issue.4 , pp. 387-392
    • Klein, C.A.1    Seidl, S.2    Petat-Dutter, K.3
  • 132
    • 42449119330 scopus 로고    scopus 로고
    • High-resolution array comparative genomic hybridization of single micrometastatic tumor cells
    • Fuhrmann C, Schmidt-Kittler O, Stoecklein NH et al. High-resolution array comparative genomic hybridization of single micrometastatic tumor cells. Nucleic Acids Res. 36(7), e39 (2008
    • (2008) Nucleic Acids Res , vol.36 , Issue.7
    • Fuhrmann, C.1    Schmidt-Kittler, O.2    Stoecklein, N.H.3
  • 133
    • 79957815376 scopus 로고    scopus 로고
    • Future medical applications of single-cell sequencing in cancer
    • Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med. 3(5), 31 (2011
    • (2011) Genome Med , vol.3 , Issue.5 , pp. 31
    • Navin, N.1    Hicks, J.2
  • 134
    • 84868709258 scopus 로고    scopus 로고
    • MRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer
    • Cann GM, Gulzar ZG, Cooper S et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS ONE 7(11), e49144 (2012
    • (2012) PLoS ONE , vol.7 , Issue.11
    • Cann, G.M.1    Gulzar, Z.G.2    Cooper, S.3
  • 135
    • 79953288433 scopus 로고    scopus 로고
    • Development and applications of single-cell transcriptome analysis
    • Tang F, Lao K, Surani MA. Development and applications of single-cell transcriptome analysis. Nat. Methods 8(Suppl. 4), S6-11 (2011
    • (2011) Nat. Methods , vol.8 , Issue.SUPPL.4
    • Tang, F.1    Lao, K.2    Surani, M.A.3
  • 136
    • 83255177150 scopus 로고    scopus 로고
    • Single-cell dissection of transcriptional heterogeneity in human colon tumors
    • Dalerba P, Kalisky T, Sahoo D et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol. 29(12), 1120-1127 (2011
    • (2011) Nat. Biotechnol , vol.29 , Issue.12 , pp. 1120-1127
    • Dalerba, P.1    Kalisky, T.2    Sahoo, D.3
  • 137
    • 84877865227 scopus 로고    scopus 로고
    • Complex tumor genomes inferred from single Circulating tumor Cells by array-CGH and next-generation sequencing
    • Heitzer E, Auer M, Gasch C et al. Complex tumor genomes inferred from single Circulating tumor Cells by array-CGH and next-generation sequencing. Cancer Res. 73(10), 2965-2975 (2013
    • (2013) Cancer Res , vol.73 , Issue.10 , pp. 2965-2975
    • Heitzer, E.1    Auer, M.2    Gasch, C.3
  • 140
    • 84885430462 scopus 로고    scopus 로고
    • Circulating tumor cells in high-risk nonmetastatic colorectal cancer
    • Gazzaniga P, Gianni W, Raimondi C et al. Circulating tumor cells in high-risk nonmetastatic colorectal cancer. Tumour Biol. (2013
    • (2013) Tumour Biol
    • Gazzaniga, P.1    Gianni, W.2    Raimondi, C.3
  • 141
    • 55149102183 scopus 로고    scopus 로고
    • Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-Analysis
    • Katsuno H, Zacharakis E, Aziz O et al. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-Analysis. Ann. Surg. Oncol. 15(11), 3083-3091 (2008
    • (2008) Ann. Surg. Oncol , vol.15 , Issue.11 , pp. 3083-3091
    • Katsuno, H.1    Zacharakis, E.2    Aziz, O.3
  • 142
    • 84878828739 scopus 로고    scopus 로고
    • Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: A meta-Analysis
    • Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J. Circulating Tumor Cells and Prognosis of Patients with Resectable Colorectal Liver Metastases or Widespread Metastatic Colorectal Cancer: A Meta-Analysis. Ann. Surg. Oncol. (2013
    • (2013) Ann. Surg. Oncol
    • Groot Koerkamp, B.1    Rahbari, N.N.2    Büchler, M.W.3    Koch, M.4    Weitz, J.5
  • 143
    • 77950458280 scopus 로고    scopus 로고
    • Meta-Analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer
    • Rahbari NN, Aigner M, Thorlund K et al. Meta-Analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138(5), 1714-1726 (2010
    • (2010) Gastroenterology , vol.138 , Issue.5 , pp. 1714-1726
    • Rahbari, N.N.1    Aigner, M.2    Thorlund, K.3
  • 144
    • 67650354361 scopus 로고    scopus 로고
    • Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
    • Cohen SJ, Punt CJ, Iannotti N et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann. Oncol. 20(7), 1223-1229 (2009
    • (2009) Ann. Oncol , vol.20 , Issue.7 , pp. 1223-1229
    • Cohen, S.J.1    Punt, C.J.2    Iannotti, N.3
  • 145
    • 84864033569 scopus 로고    scopus 로고
    • Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: A spanish cooperative group for the treatment of digestive tumors study
    • Sastre J, Maestro ML, Gómez-España A et al. Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors study. Oncologist 17(7), 947-955 (2012
    • (2012) Oncologist , vol.17 , Issue.7 , pp. 947-955
    • Sastre, J.1    Maestro, M.L.2    Gómez-España, A.3
  • 146
    • 79955030814 scopus 로고    scopus 로고
    • Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with dukes' stage b and c colorectal cancer
    • Iinuma H, Watanabe T, Mimori K et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J. Clin. Oncol. 29(12), 1547-1555 (2011
    • (2011) J. Clin. Oncol , vol.29 , Issue.12 , pp. 1547-1555
    • Iinuma, H.1    Watanabe, T.2    Mimori, K.3
  • 147
    • 77952419985 scopus 로고    scopus 로고
    • Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
    • Tol J, Koopman M, Miller MC et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann. Oncol. 21(5), 1006-1012 (2010
    • (2010) Ann. Oncol , vol.21 , Issue.5 , pp. 1006-1012
    • Tol, J.1    Koopman, M.2    Miller, M.C.3
  • 148
    • 0035866393 scopus 로고    scopus 로고
    • DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells
    • Jahr S, Hentze H, Englisch S et al. DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61(4), 1659-1665 (2001
    • (2001) Cancer Res , vol.61 , Issue.4 , pp. 1659-1665
    • Jahr, S.1    Hentze, H.2    Englisch, S.3
  • 149
    • 84863000299 scopus 로고    scopus 로고
    • The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
    • Diaz LA Jr, Williams RT, Wu J et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486(7404), 537-540 (2012
    • (2012) Nature , vol.486 , Issue.7404 , pp. 537-540
    • Diaz Jr., L.A.1    Williams, R.T.2    Wu, J.3
  • 150
    • 84862999938 scopus 로고    scopus 로고
    • Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    • Misale S, Yaeger R, Hobor S et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 486(7404), 532-536 (2012
    • (2012) Nature , vol.486 , Issue.7404 , pp. 532-536
    • Misale, S.1    Yaeger, R.2    Hobor, S.3
  • 151
    • 0037055554 scopus 로고    scopus 로고
    • Detection of free-circulating tumor-Associated DNA in plasma of colorectal cancer patients and its association with prognosis
    • Lecomte T, Berger A, Zinzindohoué F et al. Detection of free-circulating tumor-Associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int. J. Cancer 100(5), 542-548 (2002
    • (2002) Int. J. Cancer , vol.100 , Issue.5 , pp. 542-548
    • Lecomte, T.1    Berger, A.2    Zinzindohoué, F.3
  • 152
    • 84877806778 scopus 로고    scopus 로고
    • Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
    • Heitzer E, Auer M, Hoffmann EM et al. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int. J. Cancer 133(2), 346-356 (2013
    • (2013) Int. J. Cancer , vol.133 , Issue.2 , pp. 346-356
    • Heitzer, E.1    Auer, M.2    Hoffmann, E.M.3
  • 154
    • 84891740745 scopus 로고    scopus 로고
    • Prospective evaluation of methylated sept9 in plasma for detection of asymptomatic colorectal cancer
    • For The PRESEPT Clinical Study Steering Committee Investigators And Study Team
    • Church TR, Wandell M, Lofton-Day C et al.; for the PRESEPT Clinical Study Steering Committee, Investigators and Study Team. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut (2013
    • (2013) Gut
    • Church, T.R.1    Wandell, M.2    Lofton-Day, C.3
  • 155
    • 83355163991 scopus 로고    scopus 로고
    • Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
    • Warren JD, Xiong W, Bunker AM et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 9, 133 (2011
    • (2011) BMC Med , vol.9 , pp. 133
    • Warren, J.D.1    Xiong, W.2    Bunker, A.M.3
  • 156
    • 56649094216 scopus 로고    scopus 로고
    • Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay
    • Grützmann R, Molnar B, Pilarsky C et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE 3(11), e3759 (2008
    • (2008) PLoS ONE , vol.3 , Issue.11
    • Grützmann, R.1    Molnar, B.2    Pilarsky, C.3
  • 157
    • 10744233937 scopus 로고    scopus 로고
    • Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
    • Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96(4), 261-268 (2004
    • (2004) J. Natl. Cancer Inst , vol.96 , Issue.4 , pp. 261-268
    • Umar, A.1    Boland, C.R.2    Terdiman, J.P.3
  • 158
    • 76349103272 scopus 로고    scopus 로고
    • Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
    • Ameri K, Luong R, Zhang H et al. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br. J. Cancer 102(3), 561-569 (2010
    • (2010) Br. J. Cancer , vol.102 , Issue.3 , pp. 561-569
    • Ameri, K.1    Luong, R.2    Zhang, H.3
  • 159
    • 84862234603 scopus 로고    scopus 로고
    • A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells
    • Kang JH, Krause S, Tobin H, Mammoto A, Kanapathipillai M, Ingber DE. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip 12(12), 2175-2181 (2012
    • (2012) Lab Chip , vol.12 , Issue.12 , pp. 2175-2181
    • Kang, J.H.1    Krause, S.2    Tobin, H.3    Mammoto, A.4    Kanapathipillai, M.5    Ingber, D.E.6
  • 160
    • 79952770095 scopus 로고    scopus 로고
    • Circulating tumour cells: Their utility in cancer management and predicting outcomes
    • Krebs MG, Hou JM, Ward TH, Blackhall FH, Dive C. Circulating tumour cells: Their utility in cancer management and predicting outcomes. Ther. Adv. Med. Oncol. 2(6), 351-365 (2010
    • (2010) Ther. Adv. Med. Oncol , vol.2 , Issue.6 , pp. 351-365
    • Krebs, M.G.1    Hou, J.M.2    Ward, T.H.3    Blackhall, F.H.4    Dive, C.5
  • 161
    • 45849089879 scopus 로고    scopus 로고
    • Exploring the role of cancer stem cells in radioresistance
    • Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat. Rev. Cancer 8(7), 545-554 (2008
    • (2008) Nat. Rev. Cancer , vol.8 , Issue.7 , pp. 545-554
    • Baumann, M.1    Krause, M.2    Hill, R.3
  • 162
    • 33750313208 scopus 로고    scopus 로고
    • Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells
    • Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66(19), 9339-9344 (2006
    • (2006) Cancer Res , vol.66 , Issue.19 , pp. 9339-9344
    • Clarke, M.F.1    Dick, J.E.2    Dirks, P.B.3
  • 163
    • 42949150219 scopus 로고    scopus 로고
    • Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer
    • Stoecklein NH, Hosch SB, Bezler M et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection
    • (2008) Cancer Cell , vol.13 , Issue.5 , pp. 441-453
    • Stoecklein, N.H.1    Hosch, S.B.2    Bezler, M.3
  • 164
    • 80051549354 scopus 로고    scopus 로고
    • Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases
    • Rahbari NN, Reissfelder C, Mühlbayer M et al. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases. Ann. Surg. Oncol. 18(8), 2182-2191 (2011
    • (2011) Ann. Surg. Oncol , vol.18 , Issue.8 , pp. 2182-2191
    • Rahbari, N.N.1    Reissfelder, C.2    Mühlbayer, M.3
  • 165
    • 84865803081 scopus 로고    scopus 로고
    • Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA
    • Gorges TM, Schiller J, Schmitz A et al. Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. Biomarkers 17(6), 498-506 (2012
    • (2012) Biomarkers , vol.17 , Issue.6 , pp. 498-506
    • Gorges, T.M.1    Schiller, J.2    Schmitz, A.3
  • 166
    • 84857076207 scopus 로고    scopus 로고
    • Quantitative cell-free DNA KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan
    • Spindler KL, Pallisgaard N, Vogelius I, Jakobsen A. Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan. Clin. Cancer Res. 18(4), 1177-1185 (2012
    • (2012) Clin. Cancer Res , vol.18 , Issue.4 , pp. 1177-1185
    • Spindler, K.L.1    Pallisgaard, N.2    Vogelius, I.3    Jakobsen, A.4
  • 167
    • 84861512882 scopus 로고    scopus 로고
    • Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients
    • Levy M, Benesova L, Lipska L et al. Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients. Anticancer Res. 32(5), 1621-1626 (2012
    • (2012) Anticancer Res , vol.32 , Issue.5 , pp. 1621-1626
    • Levy, M.1    Benesova, L.2    Lipska, L.3
  • 168
    • 64249099411 scopus 로고    scopus 로고
    • 7th Edition). Edge SB Byrd DR Compton CC Fritz AG Greene FL Trotti A (Eds Springer, NY, USA
    • AJCC Cancer Staging Manual (7th Edition). Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (Eds). Springer, NY, USA (2010
    • (2010) AJCC Cancer Staging Manual


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.